甲狀腺激素和抗甲狀腺藥Thyroid_第1頁
甲狀腺激素和抗甲狀腺藥Thyroid_第2頁
甲狀腺激素和抗甲狀腺藥Thyroid_第3頁
甲狀腺激素和抗甲狀腺藥Thyroid_第4頁
甲狀腺激素和抗甲狀腺藥Thyroid_第5頁
已閱讀5頁,還剩28頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

甲狀腺激素和抗甲狀腺藥Thyroidhormonesandantithyroiddrugs北京協(xié)和醫(yī)學(xué)院基礎(chǔ)醫(yī)學(xué)院藥理學(xué)系葉菜英甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第1頁!SummaryThyroidhormones

Necessarytomaintainnormalmetabolism,growthanddevelopment.Hypothyroidism

CauseCretinismifithappensinembryoorneonatalperiod.Causemyxedemaifithappensinadultswhenthethyroidhormonecouldbeusedinreplacementtherapy.Hyperthyroidism

Asyndromcharacterizedbythyroidoversecretionandmetabolicdisordercausedbymultiplereasons.Itcanbetreatedwithradioactiveiodine(131I)irradation,antithyroiddrugsandoperation.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第2頁!ThyroidhormonesThyroxine,T4Triiodothyreninumnatricum,T3Synthesizedandsecretedbythyroid甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第3頁!抗甲狀腺藥分為4類:硫脲類Thiourea碘和碘化物(復(fù)方碘溶液,lugol’ssolution)

)放射性碘(131I)β受體阻斷藥(心得安等從略)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第4頁!ThyroidhormonesareiodicaminoacidsActiveponentsThyroxine,T4Triiodothyreninumnatricum,T3ChemicalconstitutionThyroidhormones甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第5頁!PhysiologicaldispositionofthyroidhormonesAbsorbedrapidlywhentakeorally,activityT3>T4,maintainingtimeT4>T3.T1/2ofT4andT3are6-7daysand1-2days,respectively.Deiodinationinmitochondriaofliverandkidney,eliminatedbykidneyafferconjugatedwithglucuronic

acidandsulfuricacid.T3,T4canalsopasstheplacentaandentermilk.Figure:theamountofnormaladults’thyroidhormonesproducedandmetabolizeddaily.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第6頁!Stepsofthyroidhormonessynthesis,releaseandregulation(Ⅰ)Iodineuptake:I-inbloodcanbeuptakenintocellsbyiodinepumpintheadenocytemembrane.Theaminoacidscanbeusedtosynthesizethyroidglobulinincells.Iodineactivationandtyrosineiodation:I-uptakenintocellscanbeoxydizedtoactiveiodinebyperoxydase.ActiveiodinebindstotyrosineofTGandformsmonoiodotyrosine(MIT)and

diiodotyrosine(DTT).甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第7頁!Synthesis,storageandreleaseofthyroidhormone

GastrointestinalI-Blood

I-I-PeroxidaseIoTGTyrIodationMITDITCon-den-sationMIT+DITDIT+DITT3T4TGAcinarluminaStorageSynthesisReleaseActivationProteaseT3T4MIT一碘酪氨酸DIT二碘酪氨酸TG甲狀腺球蛋白blood甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第8頁!Mechanismofaction(figure)ItisbelievednowthatthethermogenicactionofT3andT4isduetotheincreaseofsodiumpumpsactivityonthecellmembrane.Na+,K+—ATPaseactivityATPutilizationADPconcentrationmitochondriarespirationoxideconsumptionandheatproductionThyroidhormones甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第9頁!ThyroidclinicalapplicationReplacementtherapymainlyTherapyanddiagnosisApplication

Cretinism

Treatingtheinfantsandchildrenassoonaspossiblecouldcurethemtonormal.Iftreatingtoolate,theyneedtobetreatedalifetime.

MucousedemaIncreasethedosageofthyroidpalletgradually.Toolargedosagemayaggravateheartdiseases.Patientsinashouldbegivenafistaid,whichisinfusionofT3(40-120μg)intravenoiusly,reinjection5-15μgevery6handoraladministrationwhenawake.Hypopituitarismpatientsshouldbegivencorticalhormonefirstandfollowedbythyroidhormone.Simplegoiter ReplacementtherapycaninhibitTSHoversecretionandcontracttheglandularorgan,3-6months.T3inhibitiontestDifferentialdiagnosisforPatientswithiodinehighuptake.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第10頁!AntithyroidDrugsTherapiesofhyperthyrosisinclude131Iradiotherapy,exairesisormedication.Thioureahomologuesaremainlyusedclinically.Iodineandiodideareusedjustinpreparationforoperationsandthyroidcrisistherapy.βreceptorblockerscanbeusedasadjunctivetherapyforthyroidcrisis.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第11頁!ThioureaPhysiologicalprocessAbsorption:

Easytobeabsorbedwhentakenorally.Thiouracilisthemostfasttobeabsorbed.Thebioavailabilityis80%andtheplasmaproteinbindingrateis75%.20-30minafteradministration,thedrugturnstobeeeffectivewithT1/2of2h.Imidazoleisabsorbedslowly.T1/2oftapazoleis6h.Distribution:

Organsgenerallyalloverthebodyandcanpasstheplacenta.Theconcentrationinlactoisabout3timesasinblood.Metabolism:

Mainlyinliver,fast.60%aredestroyedinvivo,therestareeliminatedbyurineinaconjugativeform.Carbimazolefunctionsafterturningintotapazoleinvivo.

甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第12頁!PathogenesisofExophthalmoshyperthyroidism

andfunctionlinkofthioureahomologuesThisdiseaseiscausedbyanautoimmuneIgGantibodyLATS(longactingthyroidstimulator),whichcanbindtothereceptorsonthyroidadenocytesandstimulateoversecretionofthyroidhormones.Thioureahomologuescannotonlyinhibitsynthesisofthyroidhormones,butalsoLATSinpatients,whichisakindofimmunoinhibition.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第13頁!Comparisonamongmonthioureahomologuesdrugs

drugpotency

therapeuticdosemaintenanceadverseeffects

agranulemia (mg/d) doseincidence(%)incidence(%)

mildmoderatesevere

(mg/d)

Methyl 1 200-300 400-600 13.8 0.5 thiouracil 300-400 50-100Propyl 0.75 3.3 0.4thiouracilTapazole10 20-30 40-60 7.1 0.1Carbimazole10 30-40 5-10 1.9 0.8甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第14頁!IodineandiodideActionsandapplicationsLowdoseofiodine(physiologicaldose)couldpreventandcuresimple(endemicity)goiter.Add1/10000~1/100000potassiumiodideorsodiumiodidetosaltcouldpreventthedesease.LargedoseofiodinecouldinhibitthereleaseofT3andT4(duetotheinhibitionofTGhydratase).Usedasadjunctivetherapyforhyperthyroidism:①preparationbeforeoperation:administrationofaqueousiodinesolutiontwoweeksbeforeoperationdegeneratestheglandulartissue,decreasesvesselsandbleeding;②adjunctivetherapyforthyroidcrisis:couldbeusedbinedwiththioureahomologues.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第15頁!Radioactiveiodine(131I)

T1/2is8.04daysActions

131Icouldbeuptakenbythroid,participateinthesynthesisofT3,T4andisstoredinfollecularcolloid.131Imainlygeneratesβray(99%)withaverageandmaximumpathof0.5mmand2mmrespectively.Sotheirradiationfunctionislimitedinthethyroid.Itcandestroytheglandularorganbutcanseldomdestroythesurroundingtissues.Γraygeneratedby131Iaccountsfor1%andcanbedetectedinvitro.Itisusuallyusedintheexaminationofthyroidiodineuptakingfunction.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第16頁!Radioactiveiodine

AdverseeffectsandapplicationnotesHypothyroidismisthepredominantplication.Theadverseeffectscanbereducedbystrictdosecontrolandresistedbythyrine.PatientswithTotalwhitebloodcellslessthan3000/mm3arenotsuitabletotakeit.Soarepragnantandlactantwomen,patientsyoungerthan20yearsoldorwithsevereliverorkidneydeseases.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第17頁!receptorblockersClinicalapplicationAdjunctivetherapyforhyperthyroidismandhyperthyroidismcrisis.MechanismofpharmacologicalactionsExcitedsympathetic-adrenergicsystemβ1receptorblockage—heartratedropCentralβreceptorblockage—toreduceanxietyβ2receptoronNAenerginicperipheralnerveendingspresynapticmembraneblockagereducesthereleaseofNA.AppropriatelyreduceT3,T4secretion.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第18頁!硫脲類硫氧嘧啶類(thiouracil):甲基硫氧嘧啶(methykthiouracil)丙基硫氧嘧啶(propylthiouracil)咪唑類(imidazoles)他巴唑(Tapazole,甲巰咪唑methimazole)甲亢平(卡比馬唑Carbimazole)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第19頁!甲狀腺激素的化學(xué)結(jié)構(gòu)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第20頁!Synthesis,storageandregulationofthyroidhormonesIodineuptakeIodineactivationandtyrosineiodationCondensationandstorageDisintegrationandreleaseRegulation甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第21頁!Condensationandstorage:Inthethyroidglobulinmolecule,twoDTTsarecondensedtoT4,oneDTTandoneMITarecondensedtoT3,whichareallstoredinglandalveoluscolloid.Disintegrationandrelease:T3andT4arereleasedintobloodafterhydrolyzedbyproteases.Atthesametime,someofthemcanbeturnedbacktotyrosineandI-bydeiodinaseincellsandreused.Regulation:Bythepositiveandnegativefeedbackregulationofhypothalamus-anteriorlobe-thyroidaxis.HypothalamussecretsTRH,anteriorlobesecretsTSHandthyroidsynthesizeT3,T4.Stepsofthyroidhormonessynthesis,releaseandregulation(Ⅱ)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第22頁!ThyroidhormonesMechanismofactionThebindingofT3andRincreasestheuptakeofaaandglucose,resultingintheentrancetocytoplasmofT3.AfterreactingwithCBP,T3iseduced.ThefreeT3canbindRinthemitochondriaandmakeADPtoATP.Besides,itcanenterthenuclearandbindRthere,whichcanincreasethetranscriptionofDNAandthecontentofmRNA.Thenthenewproteinscanbesynthesizedandplayroles.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第23頁!Physiologicalandpharmacologicalactions

Keepnormalgrowthanddevelopment

PromotesynthesisofproteinsaswellasgrowthanddevelopmentofskeletonandCNS.T3,T4deficientsecretion:causescretinismininfantsandyoungchildrenandmucousedemainadults.

Promotemetabolismandincreaseheatproduction

Promoteoxidation,increaseoxygenconsumption,basalmetabolicrateandheatproduction.

Elevatesensitivityofsympathetic-adrenalsystem

Nervousness,trembling,heartbeatspeedup,bloodpressureincrease甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第24頁!AdverseeffectsAdverseeffectOverdoseCombinationContraindicationhyperthyreosisoldpeopleheartdiseasebishydroxycoumarindantinaoraspirindiabeteshypertensionCoronaryheartdiseasepyknocardiathyroidcrisis:anxiety,fear,restlessness,highbodytemperature,increaseandirregularheartrate,increasepulsepressure,congestiveheartfailurewithvomit,diarrheaanddehydrationwhichleadtoaanddeathAnginaorheartinfarctionIncreasetoxicityofthyroidhormone甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第25頁!硫脲類硫氧嘧啶類:甲基硫氧嘧啶丙基硫氧嘧啶咪唑類他巴唑(又稱甲巰咪唑)甲亢平(又稱卡比馬唑)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第26頁!PharmacologicalactionsInhibitperoxydaseinadenocytes,whichresultsintheinhibitedoxydationofI-toI0.Then,theiodationandcoupleoftyrosinescanbestopped.SothebiosynthesisofT3andT4isinhibited.Buttheeffectoccursslowlyastheiodineuptakeandthehormonealreadysynthesizedarenoteffected.LongtimemedicationcanleadtodecreaseofT3andT4,whichfeedbackincreasesthesecretionofTSHandmakesthyroidhyperplasyandhyperemicpensatorily.PropylthiouracilcaninhibitT4turningtoT3andcontrolT3levelinblood.Soitisthefirstchoiceinhyperthyroidismcrisis,severehyperthyroidismandpregnanthyperthyroidism.Inhibitimmuno-system(ashyperthyroidismisrelatedwithabnormalimmunoreactions).Thiourea甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第27頁!ThioureaClinicalapplicationHyperthyroidism

Forwhohasmildsymptomsandisnotsuitabletohaveoperationsand131Iradiotherapy.GiveLargerdoseatthebeginning.After1~3months,symtomsdecreasedandbasalmetabolicratereturnstoalmostnormal.Reducetomaintainingdosewithaperoidof1~2years.Alsocanbeusedasadjunctivetherapyof131Iradiotherapy.

Preparationbeforeoperation

Medicationbeforeoperationisgoodtodecreasebleedinginoperationandpreventthyroidcrisisafteroperation.Adjunctivemedicationofthyroidcrisis

Besidesintegratemeasures,largedoseofThioureahomologuescanbeusedasadjunctivetherapy,SoisPropranolol.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第28頁!ThioureaAdverseeffects

Althoughtherearelotsofadverseeffectsofthioureahomologues,incidencesofpropylthiouracilandtapazolearelower,3%and7%respectively.Commonadverseeffects:

Skinrash,headache,dinus,gastrointestinalunfortable,fatigueandsoon.

Severeadverseeffects:

Bonemarrowdepression,agranulocytosisandsoon.Note:Periodicinspectionofhemogram.Themedicationshoulebestoppedifthesymptomsaspharyngalgia,fever,cathaeresisoccur.Thyroidcancerpatientsareforbiddentotake.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論